Reprogramming of adult rod photoreceptors prevents retinal degeneration
- PMID: 23319618
- PMCID: PMC3562787
- DOI: 10.1073/pnas.1214387110
Reprogramming of adult rod photoreceptors prevents retinal degeneration
Abstract
A prime goal of regenerative medicine is to direct cell fates in a therapeutically useful manner. Retinitis pigmentosa is one of the most common degenerative diseases of the eye and is associated with early rod photoreceptor death followed by secondary cone degeneration. We hypothesized that converting adult rods into cones, via knockdown of the rod photoreceptor determinant Nrl, could make the cells resistant to the effects of mutations in rod-specific genes, thereby preventing secondary cone loss. To test this idea, we engineered a tamoxifen-inducible allele of Nrl to acutely inactivate the gene in adult rods. This manipulation resulted in reprogramming of rods into cells with a variety of cone-like molecular, histologic, and functional properties. Moreover, reprogramming of adult rods achieved cellular and functional rescue of retinal degeneration in a mouse model of retinitis pigmentosa. These findings suggest that elimination of Nrl in adult rods may represent a unique therapy for retinal degeneration.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice.Nat Commun. 2017 Mar 14;8:14716. doi: 10.1038/ncomms14716. Nat Commun. 2017. PMID: 28291770 Free PMC article.
-
Preservation of cone photoreceptors after a rapid yet transient degeneration and remodeling in cone-only Nrl-/- mouse retina.J Neurosci. 2012 Jan 11;32(2):528-41. doi: 10.1523/JNEUROSCI.3591-11.2012. J Neurosci. 2012. PMID: 22238088 Free PMC article.
-
Insulin receptor signaling in cones.J Biol Chem. 2013 Jul 5;288(27):19503-15. doi: 10.1074/jbc.M113.469064. Epub 2013 May 14. J Biol Chem. 2013. PMID: 23673657 Free PMC article.
-
Mechanism of Cone Degeneration in Retinitis Pigmentosa.Cell Mol Neurobiol. 2023 Apr;43(3):1037-1048. doi: 10.1007/s10571-022-01243-2. Epub 2022 Jul 6. Cell Mol Neurobiol. 2023. PMID: 35792991 Review.
-
Gene Therapies for Retinitis Pigmentosa that Target Glucose Metabolism.Cold Spring Harb Perspect Med. 2024 May 2;14(5):a041289. doi: 10.1101/cshperspect.a041289. Cold Spring Harb Perspect Med. 2024. PMID: 37460158 Review.
Cited by
-
Chapter 3 - Restoring Vision to the Blind: Gene Therapy for Vision Loss.Transl Vis Sci Technol. 2014 Dec 30;3(7):5. doi: 10.1167/tvst.3.7.5. eCollection 2014 Dec. Transl Vis Sci Technol. 2014. PMID: 25653889 Free PMC article. No abstract available.
-
Potentials of Cellular Reprogramming as a Novel Strategy for Neuroregeneration.Front Cell Neurosci. 2018 Nov 30;12:460. doi: 10.3389/fncel.2018.00460. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30555303 Free PMC article. Review.
-
Nuclear Receptor Subfamily 2 Group E Member 3 (NR2E3): Role in Retinal Development and Disease.Genes (Basel). 2023 Jun 23;14(7):1325. doi: 10.3390/genes14071325. Genes (Basel). 2023. PMID: 37510230 Free PMC article. Review.
-
Direct Conversion of Somatic Cells into Induced Neurons.Mol Neurobiol. 2018 Jan;55(1):642-651. doi: 10.1007/s12035-016-0350-0. Epub 2016 Dec 16. Mol Neurobiol. 2018. PMID: 27981499 Review.
-
The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.Yale J Biol Med. 2017 Dec 19;90(4):533-541. eCollection 2017 Dec. Yale J Biol Med. 2017. PMID: 29259519 Free PMC article. Review.
References
-
- Daiger SP, Rossiter BJF, Greenberg J, Christoffels A, Hide W. 1998. RetNet, the Retinal Information Network. Available at https://sph.uth.edu/RetNet/. Accessed August 10, 2012.
-
- Montana CL, Corbo JC. Inherited diseases of photoreceptors and prospects for gene therapy. Pharmacogenomics. 2008;9(3):335–347. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
